Improve clinical outcomes
Each year, approximately half of medication is not taken properly, which leads to over $300 billion in avoidable healthcare spend: often a result of emergency visits and hospitalizations caused by worsening conditions. With emocha’s program, patients with asthma, diabetes, and hypertension improve their inhaler technique, asthma control scores, HbA1C, and blood pressure.
Increase true adherence
Traditional measures to understand adherence, such as medication possession ratios, do not account for actual nonadherence. emocha measures adherence by assessing the number of observed doses divided by expected doses, proving up to 98% adherence.
Decrease medical spend
When patients adhere to their medications, they have fewer hospitalizations, readmissions, and ED visits. Adherence also helps patients avoid disease progression and more expensive treatment, avoiding thousands of dollars in cost per patient per year.
Strengthen quality measures
emocha improves direct medication adherence, thereby helping patients achieve improved clinical outcomes. This enables plans to meet quality measure targets including HEDIS and STAR measures across several domains of care: Asthma Medication Ratio, HbA1c control, blood pressure, and LDL.
By creating a daily connection with our members, this new program will help to improve healthcare for the most vulnerable.
Adherence Service Features
Outreach & Enrollment
Through targeted recruitment initiatives including email, phone, and SMS, emocha conducts outreach to patients through in-person or remote onboarding and enrolls them in the program.
Daily Observation & Assessment
emocha’s clinical team evaluates patient submissions to determine if medication was taken, side effects were reported, proper technique was followed, and dosage was correct.
Patient Support & Engagement
Because human engagement drives adherence, emocha connects with patients through a daily interaction to foster relationships.
Adherence Analytics
Providers and care team members have access to detailed dashboards surrounding dose-by-dose adherence to accurately understand both patient and population-level progress.